TrialClinical and translational science2025

A phase I, randomized, placebo-controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults.

Xiaomeng Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.